For instance, the TCF3::HLF fusion, which results from a t (17;19) (q22;p13) rearrangement, occurs in a very small proportion—close to 1%—of childhood ALL cases, yet it is now well established that this alteration confers a particularly aggressive disease course and poor survival outcome [23]. This evidence concerns the gene HLF and acute lymphoblastic leukemia.